| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 77,344 | 87,721 | ||
| Marketable securities | 251,965 | 291,992 | ||
| Prepaid expenses and other current assets | 6,829 | 5,891 | ||
| Total current assets | 336,138 | 385,604 | ||
| Property and equipment, net | 561 | 665 | ||
| Other assets | 5,475 | 4,394 | ||
| Operating lease right-of-use assets, net | 789 | 942 | ||
| Total assets | 342,963 | 391,605 | ||
| Accounts payable | 3,515 | 8,844 | ||
| Accrued expenses and other current liabilities | 15,828 | 10,454 | ||
| Current portion of operating lease liabilities | 832 | 821 | ||
| Total current liabilities | 20,175 | 20,119 | ||
| Operating lease liabilities | 213 | 425 | ||
| Income taxes payable | 6,795 | 6,645 | ||
| Total liabilities | 27,183 | 27,189 | ||
| Common stock, 0.001 par value 300,000,000 shares authorized 78,126,796 and 84,463,059 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 78 | 81 | ||
| Additional paid-in capital | 793,166 | 799,951 | ||
| Accumulated other comprehensive gain | 238 | 37 | ||
| Accumulated deficit | -477,702 | -435,653 | ||
| Total stockholders equity | 315,780 | 364,416 | ||
| Total liabilities and stockholders equity | 342,963 | 391,605 | ||
Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR)